Subhasis Roy
Director of Finance/CFO chez Kinarus AG
Profil
Subhasis Roy is the founder of Sirius Healthcare Partners GmbH, which was founded in 2009.
He was the Managing Partner from 2009 to 2018.
Currently, he is the Director at Vaccentis AG since 2022 and also holds the position of Chief Financial Officer at Kinarus AG.
In his former positions, he was the Chief Executive & Operating Officer at Novaremed AG from 2018 to 2021 and the Chief Financial Officer at NLS Pharmaceutics Ltd.
from 2021 to 2022.
He also held the position of Chief Financial Officer at Kinarus Therapeutics Holding AG.
Mr. Roy graduated from the University of Mumbai and holds an MBA from The Fuqua School of Business.
Postes actifs de Subhasis Roy
| Sociétés | Poste | Début |
|---|---|---|
Kinarus AG
 Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The private company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Director of Finance/CFO | - |
| Vaccentis AG | Director/Board Member | 01/05/2022 |
Anciens postes connus de Subhasis Roy
| Sociétés | Poste | Fin |
|---|---|---|
| NLS PHARMACEUTICS LTD. | Director of Finance/CFO | 06/06/2022 |
Novaremed AG
 Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Chief Executive Officer | 01/01/2021 |
Sirius Healthcare Partners GmbH
 Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Founder | 01/03/2018 |
| KINARUS THERAPEUTICS HOLDING AG | Director of Finance/CFO | - |
Formation de Subhasis Roy
| University of Mumbai | Graduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NLS PHARMACEUTICS LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Health Technology |
Sirius Healthcare Partners GmbH
Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Finance |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The private company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Health Technology |
| Vaccentis AG | |
Kinarus Therapeutics Holding AG
 Kinarus Therapeutics Holding AG Pharmaceuticals: MajorHealth Technology Curatis Holding AG is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. The company was founded on April 8, 1997 and is headquartered in Basel, Switzerland. | Health Technology |
